Cargando…

PATELLAR FRACTURE IN ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION: IN VITRO ANALYSIS

OBJECTIVE: To determine, by biomechanical analysis, safe patellar cut limits in anterior cruciate ligament (ACL) reconstruction that minimize fracture risks. METHODS: From three-dimensional reconstruction, triangular cuts were made in the patella, with a depth of 6.5 mm and variable width and length...

Descripción completa

Detalles Bibliográficos
Autores principales: FERRER, MARCELO DE ALMEIDA, LOBO, MARIANA DE OLIVEIRA, ALMEIDA, LAÍS MARIA PINTO, FREITAS, ANDERSON, MACEDO NETO, SÍLVIO LEITE DE, PAIVA, LEONARDO MORAIS, BATTAGLION, LEONARDO RIGOBELLO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158969/
https://www.ncbi.nlm.nih.gov/pubmed/37151730
http://dx.doi.org/10.1590/1413-785220233102e259557
Descripción
Sumario:OBJECTIVE: To determine, by biomechanical analysis, safe patellar cut limits in anterior cruciate ligament (ACL) reconstruction that minimize fracture risks. METHODS: From three-dimensional reconstruction, triangular cuts were made in the patella, with a depth of 6.5 mm and variable width and length (10 to 20 mm and 8 to 12 mm, respectively, both with an interval of 1 mm). The combinations of cuts constituted 55 models for tests, with five variations in width and 11 variations in length, tested with the finite element method (FEM). RESULTS: The mean of the localized principal maximum (traction force) values was 4.36 Pa (SD 0.87 ± 0.76) and the localized principal minimum (compression force) was −4.33 Pa (SD 1.05 ± 1.11). Comparing width and length to the tension force of the values of the main maximum, we found statistical significance from 11 mm for width and 13 mm for length. CONCLUSION: In ACL reconstruction, the removal of the patellar bone fragment is safe for fragments smaller than 11 mm in width and 13 mm in length, which corresponds to 24% of the width and 28% of the length of the patella used. Level of Evidence II, Comparative Prospective Study.